Market Cap 8.39B
Revenue (ttm) 3.36B
Net Income (ttm) 354.22M
EPS (ttm) N/A
PE Ratio 27.10
Forward PE 21.51
Profit Margin 10.55%
Debt to Equity Ratio 0.07
Volume 85,635
Avg Vol 115,202
Day's Range N/A - N/A
Shares Out 629.48M
Stochastic %K 6%
Beta 1.15
Analysts Strong Sell
Price Target N/A

Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously mea...

Industry: Medical Devices
Sector: Healthcare
Phone: 81 78 265 0500
Address:
1-5-1 Wakinohama-kaigandori, Chuo-ku, Kobe, Japan
Latest News on SSMXY
No data available.